Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 590* | 2021 |
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 109 | 2022 |
FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features LV Mechetina, AM Najakshin, OY Volkova, SV Guselnikov, RZ Faizulin, ... European journal of immunology 32 (1), 87-96, 2002 | 69 | 2002 |
A family of highly diverse human and mouse genes structurally links leukocyte FcR, gp42 and PECAM-1 SV Guselnikov, SA Ershova, LV Mechetina, AM Najakshin, OY Volkova, ... Immunogenetics 54, 87-95, 2002 | 68 | 2002 |
Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy E Sato, A Zaboronok, T Yamamoto, K Nakai, S Taskaev, O Volkova, ... Journal of radiation research 59 (2), 101-107, 2018 | 50 | 2018 |
FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA T Santiago, SV Kulemzin, ES Reshetnikova, NA Chikaev, OY Volkova, ... International immunology 23 (1), 43-53, 2011 | 46 | 2011 |
Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 45 | 2021 |
Analiz khozyaistvennoi deyatel'nosti pred-priyatiya [Analysis of economic activity of the enterprise] VV Kovalev, ON Volkova Moscow: Prospekt Publ, 2007 | 39 | 2007 |
Analysis of the economic activity of the enterprise VV Kovalev, ON Volkova M.: PBOYuL, 424, 2001 | 37 | 2001 |
Cloning and characterization of the human FCRL2 gene NA Chikaev, EA Bykova, AM Najakshin, LV Mechetina, OY Volkova, ... Genomics 85 (2), 264-272, 2005 | 36 | 2005 |
Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells N Masir, M Jones, M Pozzobon, T Marafioti, OY Volkova, LV Mechetina, ... British journal of haematology 127 (3), 335-343, 2004 | 34 | 2004 |
Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ... Cell Discovery 7 (1), 96, 2021 | 33 | 2021 |
Clinical outcomes of patients with COVID-19 admitted for respiratory support to the intensive care units in Russia P Glybochko, V Fomin, S Moiseev, S Avdeev, A Yavorovskiy, M Brovko, ... Klinicheskaya farmakologiya i terapiya= Clin Pharmacol Ther 29 (3), 25, 2020 | 31 | 2020 |
Analiz hozjajstvennoj dejatel'nosti predprijatija VV Kovalev, ON Volkova M.: Prospekt, 2010 | 31 | 2010 |
Analiz khozyaystvennoy deyatel'nosti predpriyatiya [Analysis of the economic performance of an enterprise] VV Kovalev, ON Volkova M.: PBOYuL, 2000 | 30 | 2000 |
BORON-NEUTRON CAPTURE THERAPY IN RUSSIA: PRECLINICAL EVALUATION OF EFFICACY AND ERSPECTIVES OF ITS APPLICATION IN NEURO-ONCOLOGY AA Zaboronok, VA Byvaltsev, VV Kanygin, AI Iarullina, AI Kichigin, ... New Armenian Medical Journal 11 (1), 6-15, 2017 | 26 | 2017 |
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells SV Kulemzin, AA Gorchakov, AN Chikaev, VV Kuznetsova, OY Volkova, ... Oncotarget 9 (10), 9021, 2018 | 25 | 2018 |
Polymer-stabilized elemental boron nanoparticles for boron neutron capture therapy: Initial irradiation experiments A Zaboronok, P Khaptakhanova, S Uspenskii, R Bekarevich, L Mechetina, ... Pharmaceutics 14 (4), 761, 2022 | 24 | 2022 |
Analysis of economic activity of the enterprise: Textbook VV Kovalev, ON Volkova Moscow: Prospect Velbi, 2010 | 23 | 2010 |
Risk factors for the early development of septic shock in patients with severe COVID-19 P Glybochko, V Fomin, S Moiseev, S Avdeev, A Yavorovskiy, M Brovko, ... | 18 | 2021 |